Skip to main content
RT @bella_mehta: Our work presented at #ACR22 showing increased mast cells and tryptase activity in women with OA compar

Bella Mehta bella_mehta

3 years 10 months ago
Our work presented at #ACR22 showing increased mast cells and tryptase activity in women with OA compared to men! Food for thought - can simple allergy meds help in OA management? @RheumNow abst#1642. https://t.co/cBQZU5MXeR
RT @drdavidliew: Cancer risk with tofacitinib vs TNFi in RA:
we learned at #ACR21 that
CV-enriched pts: risk (ORAL Surve

David Liew drdavidliew

3 years 10 months ago
Cancer risk with tofacitinib vs TNFi in RA: we learned at #ACR21 that CV-enriched pts: risk (ORAL Surveillance) all comers: no risk (STAR-RA) French national healthcare database #ACR22 looks at all comers: nothing to separate tofa and TNFi. Risk begets risk ABST1984 @RheumNow https://t.co/0GG04NSP3D https://t.co/nwQz7fx21M
RT @KDAO2011: Based on your experience, will you attend #ACR23 next year ... @ACRheum @rheumnow

TheDaoIndex KDAO2011

3 years 10 months ago
Based on your experience, will you attend #ACR23 next year ... @ACRheum @rheumnow
RT @DrTrishHarkins: ⚡️Pulmonary pulse wave transit time⚡️

👉novel non-invasive echo measure of ⬆️pulm va

Patricia Harkins DrTrishHarkins

3 years 10 months ago
⚡️Pulmonary pulse wave transit time⚡️ 👉novel non-invasive echo measure of ⬆️pulm vasc tone in pulm HTN 👉hyperuricaemic pts ⬇️pPTT sugg of pulm vasc dysfn @FloodRachael #ACR22 Abst1788 @RheumNow https://t.co/ZEORWbqw6f
RT @drdavidliew: Still for me the most interesting bit from the GLORIA study (PNL 5 add-on in RA) is the coming off of i

David Liew drdavidliew

3 years 10 months ago
Still for me the most interesting bit from the GLORIA study (PNL 5 add-on in RA) is the coming off of it. Patients were able to come off their long-term low-dose prednisolone. No Sx/biochem differences vs placebo. True #squadgoals for rheumatologists ABST2000 #ACR22 @RheumNow https://t.co/eQLcgqA1SN https://t.co/RGTCrMhld7
RT @doctorRBC: Cumulative dose and exposure to methotrexate were not predictors of hepatic fibrosis.
Hepatic fibrosis a

Robert B Chao, MD doctorRBC

3 years 10 months ago
Cumulative dose and exposure to methotrexate were not predictors of hepatic fibrosis. Hepatic fibrosis as measured by elastography associated with daily EtOH use. #ACRBest Abs#2147 @RheumNow #ACR22
RT @bella_mehta: Peritonitis of the #FMF - misdiagnosed as acute abdomen
Acute appendicitis is the leading cause of acut

Bella Mehta bella_mehta

3 years 10 months ago
Peritonitis of the #FMF - misdiagnosed as acute abdomen Acute appendicitis is the leading cause of acute abdomen in FMF Turkish study 1655 #FMF pts 15.8% appendectomy rates! CRP ineffective for differing FMF from appendicitis :( @RheumNow #ACR22 abst#1839
RT @doctorRBC: Factors associated with non-achievement of MDA in PsA pts receiving golimumab:
Baseline tender joint coun

Robert B Chao, MD doctorRBC

3 years 10 months ago
Factors associated with non-achievement of MDA in PsA pts receiving golimumab: Baseline tender joint count, fibromyalgia, older age, smoking, high BMI Abs#2109 @RheumNow #ACR22 https://t.co/dEzQxVtavh
RT @DrTrishHarkins: ‼️‼️Frailty ‼️‼️

👉Important predictor of serious infxn in RA pts on b- or tsDMAR

Patricia Harkins DrTrishHarkins

3 years 10 months ago
‼️‼️Frailty ‼️‼️ 👉Important predictor of serious infxn in RA pts on b- or tsDMARD irrespective of age ‼️‼️ @NamrataRheum illustrating yet another reason why it is so NB to evaluate 4 frailty in ALL (incl young) pts with RA #GeriRheum Abst2218 @RheumNow #ACR22 https://t.co/J4XQFmVoUw
RT @uptoTate: While there are limitations to this study (respondents over childbearing age, white, educated, insured), w

Dr. Rachel Tate uptoTate

3 years 10 months ago
While there are limitations to this study (respondents over childbearing age, white, educated, insured), within 2 months of @USSupremeCourt3's overturn of Roe v Wade, 1 in 17 MTX pts experienced a barrier to getting rx filled. ABS L09 @RheumNow #ACR22 https://t.co/WuikwO1bZ9 https://t.co/4Ve0zAVxbG
RT @doctorRBC: Early psoriasis and enthesitis response in PsA pts treated with guselkumab predicted longterm clinical re

Robert B Chao, MD doctorRBC

3 years 10 months ago
Early psoriasis and enthesitis response in PsA pts treated with guselkumab predicted longterm clinical response including MDA, DAPSA LDA, DAPSA50, DAPSA remission. Pts w/o early response, only half achieved remission Abs#2115 @RheumNow #ACR22 https://t.co/dnsQcp7cEq
RT @uptoTate: BKZ showed clinically meaningful improvements in efficacy outcomes in bDMARD-naïve PsA pts at Wk 16 throu

Dr. Rachel Tate uptoTate

3 years 10 months ago
BKZ showed clinically meaningful improvements in efficacy outcomes in bDMARD-naïve PsA pts at Wk 16 through wk 52. No new safety signals. ABS L02 #ACR22 @RheumNow https://t.co/Dph32O7NWG https://t.co/d7Yq3JISyF
RT @drdavidliew: I think this has changed my mind!

Does RA benefit from changes in diet & exercise?

RCT Reade @ams

David Liew drdavidliew

3 years 10 months ago
I think this has changed my mind! Does RA benefit from changes in diet & exercise? RCT Reade @amsterdamumc n=77 mod active RA https://t.co/5Iw6hYJzGK for 16w: whole food plant-based diet/exercise/stress management 0.9 improvement in DAS28 vs placebo! ABST1998 #ACR22 @RheumNow https://t.co/u10RqmPMPd
RT @doctorRBC: PsA bDMARD "ranking" system by systematic literature review looked at 30 RCTs
Highest probability of achi

Robert B Chao, MD doctorRBC

3 years 10 months ago
PsA bDMARD "ranking" system by systematic literature review looked at 30 RCTs Highest probability of achieving ACR20 and PASI90: infliximab, golimumab and bimekizumab #ACRBest Abs#2123 @RheumNow #ACR22 https://t.co/KpW0p2KAQZ
RT @DrTrishHarkins: 🔥PrEP 4 SARS-CoV-2🔥
➡️casirivimab/imdevimab

⚡️Detection @ D1 and stabilisation u

Patricia Harkins DrTrishHarkins

3 years 10 months ago
🔥PrEP 4 SARS-CoV-2🔥 ➡️casirivimab/imdevimab ⚡️Detection @ D1 and stabilisation up to D30 of serum and saliva Abs in IMID pts who failed response 2 COVID vax. ❓role in preventing severe infxn in high risk pts refractory 2 vax #ACR22 @RheumNow Abst 2195 @Dr_David_Simon https://t.co/Zd00P5l363
×